Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease: a Prospective, Multicenter, Randomized, Open-label, Clinical Trial

NCT03323476 is registered in ClinicalTrials.gov with Centre Hospitalier Departemental Vendee as lead sponsor.

NCT NCT03323476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03323476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease: a Prospective, Multicenter, Randomized, Open-label, Clinical Trial
Lead sponsor
Centre Hospitalier Departemental Vendee
Phase
Phase 3
Overall status
Active, not recruiting
Start date
February 2, 2018
Completion date
March 31, 2031
Enrollment
136 (estimated)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

anti-neutrophil cytoplasmic antibody-associated vasculitis, end stage renal disease